Records containing: SARS-CoV-2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-03-29Randomized Study on Determine the Expression of the Furin Protein in Patients With Confirmed COVID-19 Disease (in Various Phases of the Disease), Recovered From SARS-CoV-2 and Vaccinated Against Coronavirus (All Types of Vaccines)
-
CLINICAL_TRIALS study record update · 2023-03-16A Cohort Study to Evaluate Safety and Immunogenicity of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (LVRNA012) in Participants Aged 18 Years and Over in China
-
CLINICAL_TRIALS study record update · 2023-03-16FREEDOM COVID Anticoagulation Strategy Randomized Trial
-
CLINICAL_TRIALS study record update · 2023-02-28Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
-
CLINICAL_TRIALS study record update · 2023-02-28A Single-center, Randomized, Blinded, Placebo-controlled Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of One Dose of the SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in People Aged 18 Years and Older Who Had Received Two or Three Doses of Inactivated COVID-19 Vaccine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-21A Global Multi-center, Randomized, Blinded, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19 in Participants Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2023-02-21Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID)
-
CLINICAL_TRIALS study record update · 2023-02-14A Preliminary Exploratory Cohort Study to Evaluate Safety, Tolerability and Immunogenicity of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (LVRNA012) in Participants Aged 18 Years and Over in China
-
CLINICAL_TRIALS study record update · 2023-02-14A Cohort Study to Evaluate Safety and Immunogenicity of COVID-19 mRNA Vaccine, Bivalent (LVRNA021) in Participants Aged 18 Years and Over in China
-
CLINICAL_TRIALS study record update · 2023-02-14A Preliminary Exploratory Cohort Study to Evaluate Safety, Tolerability and Immunogenicity of COVID-19 mRNA Vaccine, Bivalent (LVRNA021) in Participants Aged 18 Years and Over in China
-
CLINICAL_TRIALS study record update · 2023-02-02A Randomized, Blinded, Parallel-controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccine (LVRNA009) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated 2 Doses Inactivated SARS-CoV-2 Vaccine
-
CLINICAL_TRIALS study record update · 2023-01-30COVID-19: A Phase 1, Partially Blind, Placebo-controlled, Dose Escalation, First-in-human, Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity After 1 and 2 Doses of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV Administered Intramuscularly in Healthy Adults
-
CLINICAL_TRIALS study record update · 2023-01-17The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community
-
CLINICAL_TRIALS study record update · 2023-01-13Phase 1 Study Evaluating the Safety and Immunogenicity of COVI-VAC as a Booster Dose in Previously Vaccinated Adults Against COVID-19
-
CLINICAL_TRIALS study record update · 2023-01-04A Randomised Double-blind Placebo-controlled Trial to Determine the Safety and Efficacy of Inhaled SNG001 (IFN-β1a for Nebulisation) for the Treatment of Patients With Confirmed SARS-CoV-2 Infection
-
CLINICAL_TRIALS study record update · 2023-01-04Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
-
CLINICAL_TRIALS study record update · 2022-12-30A Phase 2a, Randomized, Observer-Blind, Placebo Controlled, Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 SARS-COV-2 Vaccine in Adults Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2022-11-17A Randomized, Double-blind, Dose-ranging, Placebo Controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 (INTEGRIS-ARDS)
-
CLINICAL_TRIALS study record update · 2022-11-16Clinical Evaluation of a SARS-CoV-2 CoviDx™COVID-19 Antigen Self-Test
-
CLINICAL_TRIALS study record update · 2022-11-03Passive Immunity Trial for Our Nation (PassItOn)
-
CLINICAL_TRIALS study record update · 2022-11-03Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination: A Prospective, Randomized, Double-blind, Placebo-Controlled Trial (Trial 2)
-
CLINICAL_TRIALS study record update · 2022-11-02Household Transmission Dynamics and Viral Load Among Asymptomatic SARS-CoV-2 Infected Children
-
CLINICAL_TRIALS study record update · 2022-11-01An Open-Label, Phase 1 Clinical Study to Determine the Safety and Preliminary Immunogenicity of SARS-CoV-2 Variant mRNA Vaccine (LVRNA010) in Healthy Participants Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2022-10-31Detecting SARS-CoV-2 Virus in Tears From Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2022-10-28NOWDx Test for the Detection of Antibodies to COVID-19